Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total KLA Stockholders’ Equity
Total KLA Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Jun. 30, 2020         155,461          
Beginning balance at Jun. 30, 2020 $ 2,681,010 $ (5,530) $ 2,665,424 $ (5,530)   $ 2,090,268 $ 654,930 $ (5,530) $ (79,774) $ 15,586
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 420,567   420,567       420,567      
Net loss attributable to non-controlling interest (425)                 (425)
Other comprehensive income 328   328           328  
Net issuance under employee stock plans (in shares)         172          
Net issuance under employee stock plans (25,145)   (25,145)     (25,145)        
Repurchase of common stock (in shares)         (1,027)          
Repurchase of common stock (193,897)   (193,897)     (19,400) (174,497)      
Cash dividends and dividend equivalents declared (141,555)   (141,555)       (141,555)      
Stock-based compensation expense 26,992   26,992     26,992        
Ending balance (in shares) at Sep. 30, 2020         154,606          
Ending balance at Sep. 30, 2020 2,762,345   2,747,184     2,072,715 753,915   (79,446) 15,161
Beginning balance (in shares) at Jun. 30, 2021         152,776          
Beginning balance at Jun. 30, 2021 3,375,642   3,377,554     2,175,988 1,277,123   (75,557) (1,912)
Increase (Decrease) in Stockholders' Equity                    
Net income attributable to KLA 1,068,417   1,068,417       1,068,417      
Net loss attributable to non-controlling interest 68                 68
Other comprehensive income (2,487)   (2,487)           (2,487)  
Net issuance under employee stock plans (in shares)         160          
Net issuance under employee stock plans (46,532)   (46,532)     (46,532)        
Repurchase of common stock (in shares)         (1,190)          
Repurchase of common stock (399,677)   (399,677)     (16,966) (382,711)      
Cash dividends and dividend equivalents declared (161,561)   (161,561)       (161,561)      
Stock-based compensation expense 25,216   25,216     25,216      
Ending balance (in shares) at Sep. 30, 2021         151,746          
Ending balance at Sep. 30, 2021 $ 3,859,086   $ 3,860,930     $ 2,137,706 $ 1,801,268   $ (78,044) $ (1,844)